CURIS, INC. Retained Earnings
CURIS, INC. (CRIS) had Retained Earnings of -$1.28 billion as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.28B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.27B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.25B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.27B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$1.28B 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$1.27B 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$1.25B 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$1.27B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$1.26B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | -$1.25B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | -$1.24B 10-K · filed 2026-03-24 | |
| 2024-09-30 | -$1.23B 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$1.22B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | -$1.21B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | -$1.20B 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.18B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | -$1.17B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | -$1.16B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$1.15B 10-K · filed 2024-02-08 | |
| 2022-09-30 | -$1.14B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$1.12B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$1.11B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$1.09B 10-K · filed 2023-03-13 | |
| 2021-09-30 | -$1.08B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$1.07B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$1.06B 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$1.05B 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$1.04B 10-Q · filed 2020-11-10 | |
| 2020-06-30 | -$1.03B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | -$1.03B 10-Q · filed 2020-05-12 | |
| 2019-12-31 | -$1.02B 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$1.01B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | -$1.00B 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$994.72M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$984.84M 10-K · filed 2020-03-19 | |
| 2018-09-30 | -$978.90M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | -$971.68M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | -$963.01M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | -$952.26M 10-K · filed 2019-03-26 | |
| 2017-09-30 | -$944.24M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$928.78M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$914.69M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$898.95M 10-K · filed 2018-03-08 | |
| 2016-09-30 | -$887.61M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | -$859.27M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$847.98M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$838.54M 10-K · filed 2017-03-09 | -$838.54M 10-K · filed 2016-02-29 |
| 2015-09-30 | -$825.08M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$819.53M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$811.40M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$779.56M 10-K · filed 2016-02-29 | |
| 2014-09-30 | -$773.87M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$768.29M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$766.39M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$760.83M 10-K · filed 2015-02-24 | |
| 2013-09-30 | -$756.63M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$754.76M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$753.47M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$748.50M 10-K · filed 2014-03-13 | |
| 2012-09-30 | -$736.13M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | -$732.75M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$729.86M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$732.09M 10-K · filed 2013-03-13 | |
| 2011-09-30 | -$738.15M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | -$733.94M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | -$722.23M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |